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The zonary and endotheliochorial dog placenta is the most invasive placenta of carni-
vores. The importance of matrix metalloproteinases (MMP) in placenta invasiveness 
has been determined in several mammals including species with haemochorial, epithe-
liochorial and endotheliochorial placentation. Regarding the latter, the expression of 
MMP enzymes has been studied in the cat and the mature canine placenta. The aim of 
this study was to analyse the expression and activity of MMP- 2 and MMP- 9 in the 
early dog placenta. Placentae from 18 to 30 days of pregnancy were collected from 
four bitches. Two placentae from each bitch were analysed. Placental tissue from one 
uterine horn was fixed in formaldehyde for immunohistochemistry, while marginal 
haematoma, labyrinth, non- implantative and implantative endometrium from the con-
tralateral horn were immediately frozen in dry ice for the analysis of MMP expression 
(Western blot [WB]) and activity (zymography). MMP- 2 and MMP- 9 were evidenced 
in the labyrinth, maternal glands and marginal haematoma; this finding was directly 
correlated with levels of MMP expression by WB, and with the activity of MMP- 2, 
mainly in the haematoma (the area of major remodelling of tissues). Thus, although 
MMP- 9 is well expressed in the early canine placenta, it is not active. Given the impor-
tant role of MMPs for invasiveness, maternal–foetal angiogenesis and the establish-
ment of a correct foetal nutrition, the results are consistent with the findings in other 
species in which the MMP- 2 activation precedes the MMP- 9 one in early 
placentation.
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1  | INTRODUCTION
The placenta presents marked differences amongst eutherians. Most 
carnivores, except for the hyena, develop an endotheliochorial and 
zonary type of placenta. Haemochorial type is the most invasive pla-
centa and develops in most primates, rodents and hyenas, whereas the 
epitheliochorial type is the less invasive placenta and characterizes, for 
example swine and equine placentation. By virtue of the loss of most 
endometrial structures during placentation, except for the vessels, the 
endotheliochorial placenta is considered of intermediate invasiveness 
(Enders & Carter, 2012a,b; Pfarrer, Winther, Leiser, & Dantzer, 1999; 
Wooding & Burton, 2008). However, close contact between the tro-
phoblast (TB) cells and stagnant maternal blood does occur in endo-
theliochorial placentae in some haematophagous areas where, unlike 
the labyrinth, maternal vessels are degraded. In the dog, these hae-
matophagous placental areas constitute the marginal haematoma, 
located peripherally to the placental belt (Aralla, Groppetti, Caldarini, 
Cremonesi, & Arrighi, 2013; Miglino et al., 2006).
The endotheliochorial placenta of the dog is composed by differ-
ent regions: the chorioallantoic membrane (CAM), the labyrinthine, 
junctional and deep glandular zones and the marginal haematomas 
(Wooding & Burton, 2008) (Fig. 1). The CAM is formed by the allantoic C. Barbeito and E. Cebral contributed equally to the design and leading of this work.
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endoderm, the mesenchyme of both allantoic and chorial origins and 
the TB covering the chorion. Chorioallantoic villi interdigitates with 
endometrium structures to form the labyrinth zone, where TB differ-
entiated in cyto- and syncytiotrophoblast is observed. The junctional 
zone (the releasing zone at partum) exhibits superficial glands forming 
the “spongy zone”.
The length of the normal canine gestation is approximately two 
months, or 65 days from the luteinizing hormone surge (Verstegen- 
Onclin & Verstegen, 2008). A placental labyrinth with cytotrophoblast 
and syncytiotrophoblast differentiation is already formed as soon as 
day 18 of gestation, and the organ continues its development during 
the first half of pregnancy until it is considered a mature placenta 
(Aralla et al., 2013). Marginal haematomas are well developed and 
green by 22–25 days of pregnancy (Miglino et al., 2006). Growth of 
the labyrinth depends upon remodelling of the maternal connective 
tissue and angiogenic stimuli.
Canine placentation is more invasive than that of the cat, despite 
their similarities. Absent or scarce decidual vimentin- positive cells, 
well described in cat but unsteadily identified in the dog, might par-
tially explain its higher invasiveness (Barbeito, Fernández, Gimeno, & 
Portiansky, 2004; Fernández, Barbeito, Portiansky, & Gimeno, 2000; 
Fernández et al., 2014; Kautz et al., 2015; Walter & Schönkypl, 2006). 
Furthermore, several cellular and matrix components participate in the 
invasive function of the early canine placenta. Recently, a role of galec-
tins regarding invasiveness was proposed (Conrad et al., 2016). Also, 
endothelium of foetal and maternal vessels co- expresses VEGFA and 
VEGFR1, being involved both in angiogenic cascade and in cell sig-
nalling leading to the invasion process (Gram et al. 2015; Wooding & 
Burton, 2008). Serine, cysteine and matrix metalloproteinases (MMPs) 
participate in remodelling uterine extracellular matrix (ECM) compo-
nents through the degradation of gelatin, collagens, laminin, fibronec-
tin and the establishment of vascular and anchoring links between 
foetus and mother. These coordinated and regulated actions of extra-
cellular proteolytic enzymes require a fine balance between activated 
proteases and their tissue inhibitors (TIMPs) (Cross, Werb, & Fisher, 
1994; Sternlicht & Werb, 2001).
Matrix metalloproteinasess are a group of zinc proteases with a 
similar domain structure, produced in a intracellular latent form and 
secreted as inactive precursors (pro- enzymes). Protease interactions 
exhibit considerable functional redundancy to ensure maternal and 
foetal connections. MMP- 2 (gelatinase A) and MMP- 9 (gelatinase 
B) share a similar structure and have a hydrolytic action on collagen 
type IV, which allows separation of cells from their basal lamina and, 
therefore, phenotype transformation (Teesalu, Masson, Basset, Blasi, 
& Talarico, 1999). MMP- 2 and MMP- 9 functions have been related 
to embryo implantation (Novaro et al., 2002). Most studies have been 
performed in haemochorial placentae, which possess the highest 
degree of invasiveness (Li, Hou, Zhang, & Zhang, 2014; Staun- Ram, 
Goldman, Gabarin, & Shalev, 2004; Teesalu et al., 1999; Wang, Li, 
Shao, & Zhu, 2001; Xu et al., 2000). Moreover, the presence and ac-
tivity of MMP- 2 and MMP- 9 were determined in species developing 
epitheliochorial (Vagnoni, Ginther, & Lunn, 1995) and synepithelio-
chorial placentae (Riley, Webb, Leask, McCaig, & Howe, 2000; Takagi, 
Yamamoto, Ohtani, & Miyamoto, 2007; Uekita et al., 2004; Vagnoni, 
Zheng, & Magness, 1998; Walter & Boos, 2001). Concerning feline 
endotheliochorial placentae, the expression of MMP- 2 was reported, 
while no specific immunostaining for MMP- 9 was evidenced (Walter 
& Schönkypl, 2006). In dogs, MMP- 2 was detected in the mature pla-
centa in one study, mostly in vascular structures, while little amounts 
of MMP- 9 were evidenced in the junctional zone (Beceriklisoy et al., 
2007). Moreover, Kutzler et al. found activity of both enzymes in cul-
tured canine TB cells of term placenta (Kutzler, Sahlfeld, & Fellows, 
2012).
Therefore, considering the pivotal role of MMP- 2 and MMP- 9 in 
invasiveness during early placental development, we performed this 
work to analyse the expression, localization, distribution and activity 
of these both enzymes in the early canine placenta.
2  | MATERIALS AND METHODS
2.1 | Canine placental tissue collection
The dog (Canis lupus familiaris) specimens for this study were obtained 
with owners’ approval, following elective pregnancy termination by 
ovariohysterectomy, at the Universidad Nacional de La Plata. One 
horn from each uterus was fixed by immediate immersion in 4% buff-
ered formaldehyde for 24 hr, while the contralateral horn was dis-
sected on dry ice and then stored at −70°C for molecular studies.
In order to study MMPs expression in the early canine placentae, 
and lacking the exact day of the LH surge in the bitches, we took into 
account various macroscopical and microscopical features to deter-
mine which of the samples corresponded to the first half of the preg-
nancy. Therefore, samples with crown- rump embryo length lesser than 
30 mm, in tail bud or limb bud stages and lacking noticeable digital 
grooves (Evans & Sack, 1973; Pieri et al., 2015) were chosen. Four 
pregnancies matched these criteria. In those selected specimens, 
embryo red cells exhibited characteristics of pre- liver erythropoiesis 
stages (yolk sac or aorta/gonad/mesonephros origin): nucleation, cell 
size several times larger than mature erythrocytes, cytoplasmic baso-
philia/amphophilia (McGrath & Palis, 2005; Nothdurft et al., 1984). 
Histological aspect of the labyrinth and the glandular chambers from 
F IGURE  1 Regions of the endotheliochorial placenta of the dog. 
A. Chorioallantoic membrane with mesenchyme (*). B. Labyrinth. C. 
Superficial glands forming the spongy zone. D. Endometrial stroma. E. 
Deep glands. F. Myometrium. G. Marginal haematomas
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the spongy zone also confirmed the right inclusion of those samples 
in the study, according to previous descriptions (Aralla et al., 2013; 
Barrau, Abel, Torbit, & Tietz, 1975).
Samples from two placentae of each of the four cases selected 
were processed for immunohistochemistry (IHC), Western blot (WB) 
and zymography (Zg).
For WB and Zg, samples from the labyrinth (Lab), the non- 
implantative (Non- Impl) and implantative endometrium (Impl- End) of 
each placentae were processed. Placentae from three of the four cases 
had marginal haematomas (Hem), also processed by means of WB and 
Zg.
2.2 | Immunohistochemistry
Immunohistochemistry was performed to detect MMP- 2 and MMP- 9 
expression in different zones of the early canine placenta. After for-
mol fixation for 24 hr, tissues were deparaffinized and rehydrated 
through graded series of ethanol and washed in PBS (3 × 5 min each). 
Tissues were permeabilized by incubation with PBS- 0.25% Triton 
X- 100 for 15 min at 4°C. After washing in PBS (3 × 5 min), endog-
enous peroxidase activity was blocked with 3% hydrogen peroxide 
in PBS for 30 min at room temperature (RT). After washing, sections 
were incubated with PBS- 3% non- fat dry milk in a humid chamber 
for 1 hr at RT. Then, they were incubated overnight at 4°C with the 
primary antibody goat anti- MMP- 2 (1:50/PBS) (sc- 6838; Santa Cruz 
Biotechnologies, Santa Cruz, CA, USA) or rabbit anti- MMP- 9 (1:200/
PBS) (Cat. No.444236; Calbiochem, San Diego, CA, USA). For nega-
tive controls, the primary antibody was omitted and PBS was added 
instead. After washing (3 × 5 min), sections were incubated for 1 hr 
at RT with biotinylated rabbit anti- goat secondary antibody (1:400/
PBS) (BA- 5000; Vector Laboratories, Burlingame, CA, USA) or bioti-
nylated goat anti- rabbit secondary antibody (1:300/PBS) (BA- 1000; 
Vector Laboratories, Burlingame, CA, USA) for MMP- 2 and MMP- 9, 
respectively. After washing, slides were incubated with horseradish 
peroxidase- conjugated streptavidin (1:400/PBS) (S- 911; Molecular 
Probe Inc. Oregon, USA) for 1 hr at RT. Finally, samples were revealed 
with 3- 3′- diaminobenzidine in chromogen solution (Dab Substrate kit, 
957D- 22; Cell Marque Rocklin, USA), for 20 min (MMP- 9) or 3 min 
(MMP- 2), counterstained with haematoxylin, mounted in DPX, and 
observed and photographed with an Axiophot Zeiss light microscope 
(Carl Zeiss, Inc., Oberkochen, Germany). MMP localization and distri-
bution in the different placental zones were analysed.
2.3 | Protein extraction for western blot
Total proteins of placental tissues stored at −70°C were first extracted 
by cutting in ice- cold lysis buffer containing 50 mM Tris–HCl (pH 7.4), 
1% NP- 40, 1 mM EDTA and 3 μl of protease inhibitor cocktail (Sigma 
Chemical Co., St. Louis, MO, USA). Tissues were left for 30 min on 
ice and then homogenized for 1 min. Crude homogenates were cen-
trifuged at 5,500 g for 15 min at 4°C. The supernatant was stored at 
−70°C. Protein content was determined by Bradford assay (Bio- Rad, 
Hercules, CA, USA).
2.4 | Western blot
Stored supernatant samples of labyrinth (Lab), marginal haematoma 
(Hem), non- implantative endometrium (Non- Impl) and endome-
trium of the implantative zone (Impl- End) were dissolved in sample 
buffer (500 μM Tris–HCl, pH 6.8, 10% SDS, 30% glycerol, 0.5% β- 
mercaptoethanol and 0.5% bromophenol blue), boiled for 5 min and 
immediately placed on ice. Equal amounts of proteins (100 μg/lane) 
under reducing conditions were resolved on 10% SDS–polyacrylamide 
gel (SDS–PAGE) (10% acrylamide/bisacrylamide for resolving gel and 
5% acrylamide/bisacrylamide for stacking gel) in a Mini Protean Cell 
Bio- Rad system (Bio- Rad). After SDS–PAGE, they were equilibrated in 
transfer buffer for 15 min and electrotransferred at 150 V for 90 min 
at constant voltage onto polyvinylidene difluoride membranes (Bio- 
Rad) using a Mini Trans- Blot Cell (Bio- Rad). Transfer was monitored 
by Ponceau red staining, and membranes were blocked with 2% non- 
fat dry milk in PBS- Tris containing 0.1% Tween- 20 (PBS- T) for 60 min, 
to minimize non- specific binding of primary antibody.
For MMP- 2 detection, goat anti- MMP- 2 (1:5 in PBS) antibody 
was incubated for 72 hr at 4°C, and after stripping, the rabbit anti- 
actin (Sigma Chemical Co.) (1:2,000 in PBS) was incubated for 24 hr 
at 4°C. For MMP- 9 detection, the primary antibodies rabbit anti- 
MMP- 9 (1:10) (Calbiochem) and rabbit anti- actin (Sigma Chemical Co.) 
(1:2,000) were diluted in PBS and incubated for 72 hr at 4°C. After 
washing (PBS- T), blots were incubated with the second biotinylated 
rabbit anti- goat or goat anti- rabbit (Vector Laboratories, Burlingame, 
CA, USA) (1:1,000/PBS) for 1 hr at RT. After washing (PBS- T), the re-
action was enhanced with horseradish peroxidase- conjugated strepta-
vidin (1:1,000) (Molecular Probes) for 1 hr, and blots were developed 
with an enhanced chemiluminescence system using ECL Western 
blotting system (GE Healthcare) and a bio- imaging analyser (Fujifilm 
LAS- 1000). Pre- stained protein standards (Bio- Rad) with a molecular 
weight range of approximately 250–25 kDa were used. The bands of 
MMPs of the placental zones were analysed by densitometric analysis 
(Image Scn), and optic density was normalized to actins bands.
2.5 | Gelatin zymography
Each placental zone was cut and homogenized in lysis buffer [50 mM 
Tris–HCl (pH 7.4), 5 mM CaCl2, 1 μM ZnCl2, 1% Triton X- 100], in-
cubated at RT for 2 hr and centrifuged at 13,000 × g for 15 min to 
remove cellular debris. Protein content of supernatant (100 μg) was 
determined according to the Bradford method.
Tissue lysates were mixed with zymogram sample buffer contain-
ing 10 mM Tris–HCl, 0.06% bromophenol blue, 10% glycerol and 2% 
SDS. Briefly, gelatin at a final concentration of 1 mg/ml was incorpo-
rated to 10% sodium dodecyl sulphate–polyacrylamide gel electro-
phoresis (SDS–PAGE) with 4% SDS–PAGE stacking. Aliquots from 
tissue lysate (20 μl approximately) of each sample were loaded and 
proteins electrophoresed for 1 hr at 100 V. After electrophoresis, gels 
were washed five times (5 min each) in a Tris- based solution contain-
ing 2.5% (w/v) Triton X- 100 and three times for 10 min in phosphate- 
buffered saline (PBS). Then, the gel was incubated in 50 mM Tris–HCl 
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(pH 7.5), 0.15 M NaCl and 0.005 M CaCl2 at 37
o C for 48 hr. Gels were 
stained with 0.5% (w/v) Coomassie brilliant blue R- 250 (Sigma Chem 
Co.) for 45 min, lightly destained in methanol:acetic acid:water (3:1:6) 
and finally stored in 5% (v/v) acetic acid.
Gelatin zymography was photographed with a bio- imaging analy-
ser (Fujifilm LAS- 1000). Each gelatinase band was identified by their 
molecular weight compared with pre- stained protein standards (Bio- 
Rad) with a range of approximately 250–25 kDa. Enzymatic activities, 
evaluated as intensity of clear bands in the gel, were performed by 
image analysis (Image Scn). The different placental zones were run on 
separate gels with the same amount of protein loaded on each lane. 
To establish that the gelatinolytic activity observed was due to MMPs, 
a set of extracts was pre- incubated in the presence of 0.01 M sodium 
ethylenediaminetetraacetate (EDTA) (Sigma Chemical Co.) before per-
forming electrophoresis, and gels were incubated in the presence of 
EDTA after electrophoresis; EDTA- dependent disappearance of the 
corresponding bands confirmed that activity (data not shown). The 
proteolytic activity appeared as clear bands, visualizing both the pro- 
enzyme and the smaller active form, on a blue background. The densi-
tometry of the bands was analysed on digitalized images and assessed 
by the Image Scn program.
2.6 | Statistical analysis
Mean of arbitrary units of MMP expression levels and activity and the 
SD of samples of placental tissues were analysed by one- way analysis 
of variance (ANOVA), using Tukey’s multiple post- test to determine 
differences amongst them. Data satisfied assumptions of normality 
and variance homogeneity required for ANOVA. All statistical analy-
ses were performed with the Instat Program (GraphPAD Software, San 
Diego, CA, USA). Differences were considered significant when p < .05.
3  | RESULTS
3.1 | Immunohistochemical detection of MMP- 2 and 
MMP- 9 in early placenta
MMP- 2 expression was detected in labyrinthine cytotrophoblast cells 
and syncytiotrophoblast with a strong staining. Mesenchyme from 
the CAM presented a weak immunostaining as well as embryonic en-
dothelial cells, while maternal endothelium resulted negative (Fig. 2A). 
MMP- 2 negative control is shown in Fig. 2B. MMP- 9 was also immu-
noexpressed in cytotrophoblast cells and syncytiotrophoblast (Fig. 2C), 
but with a remarkable weaker intensity than that observed for MMP- 
2. However, the allantoic mesenchyme displayed a very strong immu-
noreaction to MMP- 9, whereas expression in vascular structures was 
similar to that of MMP- 2. MMP- 9 negative control is shown in Fig. 2D.
In the endometrium, MMP- 2 was expressed in deep glands near 
to the myometrial tissue, being the expression restricted to the apical 
side of the epithelium. ECM also presented weak immunoreactivity, 
revealing MMP- 2 secretion (Fig. 3A). Results of rabbit IgG negative 
control are shown in Fig. 3B. In the superficial glands, MMP- 2 was pos-
itive in the epithelium of one side of the gland and almost negative in 
the other side (Fig. 3C). Negative control is shown in Fig. 3D. MMP- 9 
immunoexpression was also strong in the superficial gland epithelium 
(Fig. 3E). Negative control is shown in Fig. 3F. Immunohistochemical 
results are summarized in Table 1.
3.2 | Placental MMP- 2 and MMP- 9 expression 
levels and gelatinolytic activity
Taken into account the variable MMP immunoexpression in the differ-
ent cells and tissues of the foetal and maternal canine placenta, the 
F IGURE  2 Distribution and cellular 
localization of MMP- 2 and MMP- 9 
immunoexpression in labyrinth of dog early 
placenta. (A) MMP- 2 immunoexpression. 
Arrowhead points to strongly labelled 
syncytium. Maternal endothelium was 
negative (thick arrow). Mesenchyme 
presented weak immunostaining 
(asterisks). (B) Negative control for 
MMP- 2 immunoreactivity. (C) MMP- 9 
immunoexpression. Staining of trophoblast 
cells was very weak (arrowhead). Thin 
arrow points to positive embryonic 
endothelium, whereas thick arrow points 
to negative maternal endothelium. 
The mesenchyme presented strong 
immunoreaction (asterisks). (D) Negative 
control for MMP- 9 immunoreactivity. 
Scale bar: 20 μm. IHC, DAB chromogen, 
haematoxylin counterstain. MMP, matrix 
metalloproteinases
(A) (B)
(C) (D)
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interest was, initially, to analyse the whole expression levels of both 
proteases MMP- 2 and MMP- 9 in labyrinth, haematoma, implantative 
endometrium and to compare the non- implantative endometrium of 
early placenta, by WB semiquantification (Fig. 4).
This analysis showed that all zones of the placenta expressed a 
band of MMP- 2 at 55–60 kDa which corresponded to the active form 
of the protease (Fig. 4A). The MMP- 2 expression level in labyrinth was 
slightly higher than that in haematoma (Hem) (p < .05), whereas the ex-
pression in implantative endometrium (IE) was lower than that in Lab 
(p < .01) (Fig. 4A). A band of near 100 kDa of MMP- 9 was detected 
by WB in all the same tissues, but in Lab and Hem the MMP- 9 was 
expressed similarly and in a significant higher level than in the non- 
implantative and implantative endometrium (p < .001) (Fig. 4B).
Only the active form of MMP- 2 (50 kDa) was detected in all ma-
ternal and embryonic tissues studied by Zg (Fig.5A). The activity of 
MMP- 2 was highest in Hem, whereas the activity in non- IE was the 
lowest. Moreover, MMP- 2 activity in the labyrinth was significantly 
lower than the MMP- 2 activity of implantative endometrium (p < .01) 
(Fig.5A,B).
F IGURE  3 Distribution and cellular 
localization of MMP- 2 and MMP- 9 
immunoexpression in maternal zone in 
dog early placenta. (A) In deep uterine 
glands near to the myometrium (m), MMP- 
2 expression was positive in the apical 
side of the epithelium (black arrow). Also 
the extracellular matrix presented weak 
immunoreactivity (asterisks), revealing 
MMP- 2 secretion. (B) IgG negative control 
for MMP- 2 in deep uterine glands. (C) In 
the uterine chambers of superficial glands, 
MMP- 2 was positive in the epithelium of 
one side of the chamber (thin arrow) and 
negative in the other (thick arrow). (D) IgG 
negative control for MMP- 2 in superficial 
glands. (E) MMP- 9 immunoexpression 
was strong in the epithelium of superficial 
glands (arrows). Also, extracellular MMP- 9 
immunoreactivity was observed in maternal 
stroma (asterisks). (F) IgG negative control 
for MMP- 9 in superficial glands. Scale 
bar: A, B: 20 μm; C–F: 10 μm. IHC, DAB 
chromogen, haematoxylin counterstain. 
MMP, matrix metalloproteinases
(A) (B)
(C) (D)
(E) (F)
TABLE  1 Summary of localization, distribution and relative 
expression of MMP- 2 and MMP- 9 in the dog early placenta
MMP- 2 MMP- 9
Chorioallantoic membrane
Mesenchyme +/− +++
Labyrinth
Cytotrophoblast cells +++ +/−
Syncytiotrophoblast +++ +/−
Embryonic endothelium + +
Maternal endothelium − −
Endometrium
Junctional zone (epithelium of 
superficial glands)
+/− ++
Stroma − +
Immunostaining of MMPs was evaluated in tissues of labyrinth and endo-
metrium and it is summarized as relative intensity as follows: −: negative 
(without MMP reaction), +/− weakly positive reactivity, ++: moderate re-
activity, +++: strong reactivity. MMP, matrix metalloproteinases.
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4  | DISCUSSION
For several years, it was shown in haemochorial placentae from 
primates that MMPs play key roles in the processes of implantation 
and early placentation, because of its proteolytic action on vari-
ous components of the ECM (Li et al., 2014; Wang et al., 2001; 
Xu et al., 2000). These enzymes that favour invasiveness pro-
cesses were also found in TB cells of less studied species (Uekita 
et al., 2004; Vagnoni et al., 1995, 1998), even in carnivores with 
endotheliochorial placentas (Beceriklisoy et al., 2007; Walter & 
Schönkypl, 2006). The present work confirms the presence of pro-
teases MMP- 2 and MMP- 9 in the labyrinth, the maternal glands 
and the marginal haematoma of canine early placenta, together 
with the activity of MMP- 2, mainly in the haematoma. As it was 
previously observed by Beceriklisoy et al. (2007) in a later gesta-
tional state, MMP- 2 could be evidenced by IHC in the labyrinth of 
early canine placenta. MMP- 9 immunostaining, on the other hand, 
was positive in both epithelial and mesenchymal components of the 
labyrinth, contrary to previous reports in cat (Walter & Schönkypl, 
2006) and in later canine placenta (Beceriklisoy et al., 2007). The 
MMP- 2 and MMP- 9 expression extended to the implantative en-
dometrium, including deep glandular areas. According to this, we 
also demonstrated high MMP- 2 and MMP- 9 protein expression in 
labyrinth and implantative endometrium by WB. However, enzy-
matic activity in the labyrinth, the implantative endometrium and 
the marginal haematoma was limited to MMP- 2. Thus, we find that 
F IGURE  4 Expression levels of MMP- 2 and MMP- 9 in early 
dog placenta. (A) Western blot of MMP- 2. Upper figure shows 
representative canine placental tissues showing MMP- 2 protein 
bands according to molecular weight 55–60 kDa of the active form 
of the MMP- 2. Figure below shows the densitometric analysis of 
MMP- 2 protein expression levels normalized to β- actin, expressed as 
the mean optic density (OD) of MMP- 2/β actin (±SD). Lab, labyrinth; 
IE, implantative endometrium; Hem, haematoma; Non- IE, non- 
implantative endometrium. This figure shows the most significant 
increments in MMP- 2 expression levels in Lab and Hem, and the 
lowest expression in the IE and Non- IE. Lab vs IE: p < .001; Lab vs 
Hem: p < .05; Lab vs Non- IE: p < .001; Hem vs Non- IE: p < .001; 
IE vs Non- IE: p < .001 (Tukey′s test). Different letters indicate 
statistical differences. (B) Western blot of MMP- 9 Upper figure 
shows representative areas of the canine placenta showing MMP- 9 
protein according to antibody for MMP- 9, which recognizes both the 
latent pro- enzyme and the active forms, at MW of 95–110 kDa. It 
was identified only one band corresponding to MW 100 kDa. Figure 
below shows the densitometric analysis of MMP- 9 expression levels, 
normalized to β- actin, as the mean optic density (OD) of MMP- 9/β 
actin (±SD). This figure shows the highest MMP- 9 expression levels in 
Lab and Hem, and the lowest expression in IE and Non- IE. Different 
letters indicate statistical differences. Lab and Hem vs Non- IE and IE: 
p < .001 (Tukey′s test). MMP, matrix metalloproteinases
F IGURE  5 MMP- 2 and MMP- 9 gelatinolytic activities in early 
canine placenta. (A) Representative MMP- 2 and MMP- 9 gelatin 
zymography of samples of placental and maternal tissues of early 
canine placenta, showing that any form (pro- form or active) of MMP- 
9 was detected at MW range of 110–80 kDa, while the same tissues 
presented activity of the active form of MMP- 2 (molecular weight of 
50 kDa). Lane 1: labyrinth; lane 2: implantative endometrium; lane 
3: non- implantative endometrium; lane 4: haematoma. (B) Figure 
shows the activity levels of MMP- 2 of placental tissues, expressed as 
mean optic density (OD) and SD of the active gelatinolytic MMP- 
2 bands. The activity of active MMP- 2 is highest in haematoma 
(Hem) and significantly moderately increased in the implantative 
endometrium (IE). Different letters indicate statistical differences. Lab 
vs IE: p < .01; Lab vs Non- IE: p < .001; IE vs Non- IE: p < .001; IE vs 
Hem: p < .05; Non- IE vs Hem: p < .001 (Tukey′s test), MMP, matrix 
metalloproteinases
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although MMP- 9 is well expressed in the early canine placenta, it 
is not active.
In particular, the activity of the active form of MMP- 2 was highest 
in the haematoma and in the implantative endometrium. The marginal 
haematoma is the area of major remodelling of tissues, where direct 
contact occurs between the TB and the maternal blood, due to ma-
ternal vessel degradation. This area is considered by some authors 
(Stoffel, Gille, & Friess, 1998) as an area of haemochorial placentation 
within the endotheliochorial placenta. No previous works concerning 
the activity of MMPs in the canine placental haematoma were found. 
As marginal haematomas develop during early gestational period 
(Miglino et al., 2006), we studied this early period of placentation in 
canine.
Beceriklisoy et al. showed activity of both enzymes in the uter-
ine portion of the placenta and in the labyrinth of later placentas. 
However, their activity in the labyrinth and in the placental marginal 
haematoma of the first half of gestation was not clearly established 
(Beceriklisoy et al., 2007). These results are consistent with those seen 
in human placenta, where the production of MMP- 2 is high in early 
TBs and decreases in the third trimester, while MMP- 9 production in-
creases (Xu et al., 2000). Also, MMP- 2 activity is higher than that of 
MMP- 9 at the beginning of gestation (Riley et al., 1999). In the rhesus 
monkeys (Macaca mulatta), mRNA for MMP- 9 was detected on day 18 
of pregnancy, but no activity was found at that time, although it did 
appear later (Wang et al., 2001).
Conversely, in cattle, expression of MMP- 9 was very low, both in 
endometrium and in foetal placenta (Takagi et al., 2007). In the goat 
placenta, the activity of MMP- 2 is moderate in the interplacentomal 
areas, but varies in the binucleated cells, which fuse with the endome-
trial epithelium and constitute the most invasive placental component 
(Uekita et al., 2004). In sheep, the presence of these enzymes in binu-
cleated cells is controversial. Vagnoni et al. (1998) support this idea, 
while Riley et al. (2000) could not locate them, and proposed that the 
breakdown of type IV collagen necessary for these cells to migrate 
and merge with the endometrium depends on paracrine secretion of 
MMP- 2 and MMP- 9 by the uninucleate TB cells.
Although MMP- 9 activity could not be observed in early canine 
placenta in any studied area, its activity could come out at late preg-
nancy, possibly because of the pivotal role of this protease in the 
angiogenic process (Deryugina & Quigley, 2006) or in the tissue break-
down at the time of delivery (Yonemoto et al., 2006). In this regard, 
studies of the junctional zone (the placental releasing site) and of the 
endometrium in canine preterm placenta are necessary.
Predominance of inactive forms of MMP- 2 and MMP- 9 in the 
cat placenta was demonstrated by zymography (Walter & Schönkypl, 
2006). The lower activity of MMP- 2 in cats compared with levels re-
ported in dogs might be associated with the increased invasiveness 
in the placenta of the latter, and related to the occurrence of the dis-
ease known as subinvolution of the placentation sites in the bitches 
(Fernández, Portiansky, Barbeito, & Gimeno, 1998). It has not been 
studied yet whether MMP- 2 and MMP- 9 are involved in the patho-
genesis of this disease.
In our work in early canine placenta, the presence of the prote-
ases MMP- 2 and MMP- 9 was demonstrated in the labyrinth as in the 
maternal tissues, besides in marginal haematoma. However, the enzy-
matic activity of these proteases was limited to MMP- 2.
Altogether, our results, added to those of other researchers, in-
dicate that while both MMPs have similar structures and substrates, 
their expression and activity in the placenta vary according to the tis-
sue and gestational time, suggesting different involvement at specific 
times of placentation, in different groups of animals.
Changes in the activity of MMPs throughout pregnancy appear to 
be associated with the processes of invasiveness. MMPs of maternal 
tissues, in different species (Wang et al., 2001), may act on both endo-
metrial basal lamina and TB tissue, leading to the loss of the epithelial 
cell contact with the basement membrane. The relevance of the study 
of these enzymes of ECM resides in their role in the processes of inva-
siveness, maternal–foetal angiogenesis, therefore in the establishment 
of a correct foetal nutrition. In humans, a decline in the production of 
MMP- 2 and MMP- 9 was associated with growth retardation (Merchant 
et al., 2004). On the other hand, some authors (Kutzler et al., 2012) 
have argued that the canine placenta could serve as a model for study 
of human pre- eclampsia, considering the high invasive capacity of its 
cells, the fundamental role of MMPs for invasiveness and the altered 
expression of these enzymes during pre- eclampsia (Wang et al., 2010). 
Given the importance of the metalloprotease expression and activa-
tion, specific tissue and gestational period, it is necessary to perform 
further studies to establish the location, MMPs expression and activity 
of canine placenta throughout pregnancy.
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